Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Key challenges in developing CAR-T therapy for CLL

Marco Ruella, MD, University of Pennsylvania, Philadelphia, PA, highlights the major obstacles to developing CAR-T for patients with chronic lymphocytic leukemia (CLL), including T cell immune dysfunction, and the highly immunosuppressive microenvironment present in these patients. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.